\-\ Texto\\:\\ \ \(0\)\
\-\ solitary\\ 1\\.4\\ cm\\ annular\\ eczematoid\\ plaque\\ on\\ right\\ shin\ \(0\)\
\-\ the\\ initial\\ lesion\\ resolved\\ with\\ ultra\\-potent\\ topical\\ steroids\\.\\ however\\,\\ over\\ the\\ next\\ 18\\ months\\,\\ groups\\ of\\ red\\-brown\\ papules\\ occurred\\ on\\ the\\ forehead\\ and\\ cheeks\\.\\ additional\\ biopsies\\,\\ tissue\\ cultures\\,\\ and\\ tb\\ complex\\ pcr\\ studies\\ continued\\ to\\ support\\ a\\ granulomatous\\ dermatitis\\ with\\ no\\ evidence\\ of\\ infection\\ or\\ foreign\\ bodies\\.\\ the\\ new\\ lesions\\ improved\\ with\\ topical\\ and\\ intralesional\\ steroids\\.\\ ophthalmologic\\ workup\\ has\\ shown\\ no\\ evidence\\ of\\ ocular\\ involvement\\.\ \(0\)\
\-\ tissue\\ culture\\ and\\ pcr\\ studies\\ negative\\ for\\ infectious\\ etiology\\.\ \(0\)\
\-\ histopathology\\:\\ the\\ biopsy\\ shows\\ several\\ naked\\ granulomas\\ without\\ birefringent\\ material\\ within\\ the\\ dermis\\.\\ acid\\ fast\\ and\\ fungal\\ stains\\ were\\ negative\\.\ \(0\)\
\-\ case\\ 4\\,\\ \\(27th\\ annual\\ uniformed\\ services\\ dermatology\\ conference\\,\\ 2003\\)\\ etanercept\\ induced\\ sarcoidal\\ granulomas\\ of\\ the\\ skin\ \(0\)\
\-\ \\â\\€\\¢neoplasms\ \(1\)\
\-\ \\â\\€\\¢infections\ \(1\)\
\-\ \\â\\€\\¢dermatitis\ \(1\)\
\-\ 76\\ y\\/o\\ asian\\ female\\ with\\ rheumatoid\\ arthritis\\ and\\ a\\ scaly\\ lesion\\ on\\ her\\ right\\ shin\\.\\ her\\ rheumatologist\\ started\\ her\\ on\\ etanercept\\ \\(25mg\\ sc\\ biw\\)\\ one\\ month\\ prior\\ to\\ the\\ initial\\ onset\\.\\ pmh\\:\\ s\\/p\\ 6\\ months\\ inh\\ treatment\\ for\\ pulmonary\\ scaring\\ on\\ cxr\\ consistent\\ with\\ prior\\ tb\\ infection\\;\\ \\(\\+\\)\\ bcg\\ vaccination\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ etanercept\\:\\ 0\\.22548047519981798\ \(0\)\
\-\ pcr\\:\\ 0\\.19922612902198303\ \(0\)\
\-\ dermatitis\\:\\ 0\\.188798988718237\ \(0\)\
\-\ topical\\:\\ 0\\.18604902085411104\ \(0\)\
\-\ shin\\:\\ 0\\.18238001256978648\ \(0\)\
\-\ granulomas\\:\\ 0\\.17624875367797224\ \(0\)\
\-\ her\\:\\ 0\\.14688091878358442\ \(0\)\
\-\ tb\\:\\ 0\\.1395672671963913\ \(0\)\
\-\ steroids\\:\\ 0\\.13770372287965496\ \(0\)\
\-\ eczematoid\\:\\ 0\\.1253285818836737\ \(0\)\
\-\ sarcoidal\\:\\ 0\\.1253285818836737\ \(0\)\
\-\ biw\\:\\ 0\\.1253285818836737\ \(0\)\
\-\ the\\:\\ 0\\.12509913223496089\ \(0\)\
\-\ naked\\:\\ 0\\.11975815079846606\ \(0\)\
\-\ inh\\:\\ 0\\.11975815079846606\ \(0\)\
\-\ on\\:\\ 0\\.11834343424449835\ \(0\)\
\-\ birefringent\\:\\ 0\\.1158058670458161\ \(0\)\
\-\ studies\\:\\ 0\\.11497521232164057\ \(0\)\
\-\ scaly\\:\\ 0\\.11274023759990899\ \(0\)\
\-\ bcg\\:\\ 0\\.11274023759990899\ \(0\)\
\-\ conference\\:\\ 0\\.11023543596060845\ \(0\)\
\-\ 25mg\\:\\ 0\\.11023543596060845\ \(0\)\
\-\ rheumatologist\\:\\ 0\\.10811765635012079\ \(0\)\
\-\ scaring\\:\\ 0\\.10811765635012079\ \(0\)\
\-\ initial\\:\\ 0\\.10514541612928544\ \(0\)\
\-\ ophthalmologic\\:\\ 0\\.1046650048754008\ \(0\)\
\-\ cheeks\\:\\ 0\\.10321752276205137\ \(0\)\
\-\ sc\\:\\ 0\\.10190811591618017\ \(0\)\
\-\ vaccination\\:\\ 0\\.10190811591618017\ \(0\)\
\-\ intralesional\\:\\ 0\\.09961306451099151\ \(0\)\
\-\ and\\:\\ 0\\.09716357082763923\ \(0\)\
\-\ negative\\:\\ 0\\.09703502933243721\ \(0\)\
\-\ infection\\:\\ 0\\.09467843607475264\ \(0\)\
\-\ stains\\:\\ 0\\.09302451042705552\ \(0\)\
\-\ 27th\\:\\ 0\\.09238540107832255\ \(0\)\
\-\ months\\:\\ 0\\.09123382542360556\ \(0\)\
\-\ papules\\:\\ 0\\.08957185895233556\ \(0\)\
\-\ asian\\:\\ 0\\.08957185895233556\ \(0\)\
\-\ forehead\\:\\ 0\\.08907222667440556\ \(0\)\
\-\ biopsies\\:\\ 0\\.08907222667440556\ \(0\)\
\-\ evidence\\:\\ 0\\.08896436147928649\ \(0\)\
\-\ groups\\:\\ 0\\.0885901290171997\ \(0\)\
\-\ dermis\\:\\ 0\\.0885901290171997\ \(0\)\
\-\ prior\\:\\ 0\\.08769482943326173\ \(0\)\
\-\ fast\\:\\ 0\\.08640483883610749\ \(0\)\
\-\ annular\\:\\ 0\\.08524315785952925\ \(0\)\
\-\ plaque\\:\\ 0\\.08225199132476141\ \(0\)\
\-\ tissue\\:\\ 0\\.0822208873274447\ \(0\)\
\-\ acid\\:\\ 0\\.08138401597871024\ \(0\)\
\-\ ocular\\:\\ 0\\.08030594361879424\ \(0\)\
\-\ histopathology\\:\\ 0\\.0790674141793421\ \(0\)\
\-\ uniformed\\:\\ 0\\.0781511831690932\ \(0\)\
\-\ induced\\:\\ 0\\.07771500769438566\ \(0\)\
\-\ 76\\:\\ 0\\.07708565917979143\ \(0\)\
\-\ services\\:\\ 0\\.07688212399824987\ \(0\)\
\-\ with\\:\\ 0\\.07672783749824653\ \(0\)\
\-\ dermatology\\:\\ 0\\.07668156023955376\ \(0\)\
\-\ support\\:\\ 0\\.07609686036182799\ \(0\)\
\-\ culture\\:\\ 0\\.07590736255094914\ \(0\)\
\-\ occurred\\:\\ 0\\.07572044302167165\ \(0\)\
\-\ lesion\\:\\ 0\\.07514337809645862\ \(0\)\
\-\ cultures\\:\\ 0\\.07381649455234275\ \(0\)\
\-\ workup\\:\\ 0\\.07381649455234275\ \(0\)\
\-\ next\\:\\ 0\\.07318473389245703\ \(0\)\
\-\ annual\\:\\ 0\\.07243381620760461\ \(0\)\
\-\ solitary\\:\\ 0\\.07172182407004965\ \(0\)\
\-\ foreign\\:\\ 0\\.07104491999741867\ \(0\)\
\-\ pmh\\:\\ 0\\.07091345130543318\ \(0\)\
\-\ 2003\\:\\ 0\\.07052642927662034\ \(0\)\
\-\ resolved\\:\\ 0\\.07039980742662279\ \(0\)\
\-\ fungal\\:\\ 0\\.070150011936464\ \(0\)\
\-\ granulomatous\\:\\ 0\\.06966364704099667\ \(0\)\
\-\ improved\\:\\ 0\\.0695446993414845\ \(0\)\
\-\ rheumatoid\\:\\ 0\\.0690789471632709\ \(0\)\
\-\ bodies\\:\\ 0\\.06862846833123558\ \(0\)\
\-\ material\\:\\ 0\\.06601331771736378\ \(0\)\
\-\ started\\:\\ 0\\.06601331771736378\ \(0\)\
\-\ continued\\:\\ 0\\.064213202512988\ \(0\)\
\-\ arthritis\\:\\ 0\\.06373941854648812\ \(0\)\
\-\ etiology\\:\\ 0\\.06313209873790691\ \(0\)\
\-\ infectious\\:\\ 0\\.06305803724602793\ \(0\)\
\-\ cxr\\:\\ 0\\.06269360278798529\ \(0\)\
\-\ of\\:\\ 0\\.061345616007650504\ \(0\)\
\-\ additional\\:\\ 0\\.060751627118842605\ \(0\)\
\-\ shown\\:\\ 0\\.060751627118842605\ \(0\)\
\-\ complex\\:\\ 0\\.06038196248143829\ \(0\)\
\-\ 18\\:\\ 0\\.059385567106205045\ \(0\)\
\-\ skin\\:\\ 0\\.05829896358186222\ \(0\)\
\-\ involvement\\:\\ 0\\.056721505347931044\ \(0\)\
\-\ biopsy\\:\\ 0\\.05493365107562509\ \(0\)\
\-\ new\\:\\ 0\\.05421670370863051\ \(0\)\
\-\ right\\:\\ 0\\.05196492066455043\ \(0\)\
\-\ several\\:\\ 0\\.05141754279768265\ \(0\)\
\-\ no\\:\\ 0\\.050969206672348825\ \(0\)\
\-\ onset\\:\\ 0\\.05032275708598228\ \(0\)\
\-\ pulmonary\\:\\ 0\\.04776932398537925\ \(0\)\
\-\ month\\:\\ 0\\.047672574476573304\ \(0\)\
\-\ for\\:\\ 0\\.04750589153326614\ \(0\)\
\-\ however\\:\\ 0\\.04638509640386924\ \(0\)\
\-\ shows\\:\\ 0\\.04599563611549325\ \(0\)\
\-\ cm\\:\\ 0\\.04500802250854484\ \(0\)\
\-\ lesions\\:\\ 0\\.04500802250854484\ \(0\)\
\-\ one\\:\\ 0\\.04486974871109252\ \(0\)\
\-\ over\\:\\ 0\\.04357643209560519\ \(0\)\
\-\ consistent\\:\\ 0\\.04249329788327852\ \(0\)\
\-\ without\\:\\ 0\\.04133653280572307\ \(0\)\
\-\ were\\:\\ 0\\.04039679059725618\ \(0\)\
\-\ case\\:\\ 0\\.03937157316332119\ \(0\)\
\-\ to\\:\\ 0\\.03918403263731462\ \(0\)\
\-\ female\\:\\ 0\\.037816503199518715\ \(0\)\
\-\ treatment\\:\\ 0\\.03733116115134906\ \(0\)\
\-\ within\\:\\ 0\\.036094197873945175\ \(0\)\
\-\ has\\:\\ 0\\.0357965300241445\ \(0\)\
\-\ or\\:\\ 0\\.027263068668869798\ \(0\)\
